xStocks has listed five tokenized stocks and exchange-traded funds (ETFs) on Hyperliquid's HyperCore. The listed products include those related to NVIDIA, SK Hynix, and Micron. On the 11th, xStocks announced through its official channel that it has deployed NVIDIA xStocks (NVDAx), S&P 500 ETF xStocks (SPYx), Nasdaq 100 ETF xStocks (QQQx), SK Hynix xStocks (SKHYx), and Micron xStocks (MUx) on HyperCore. Additional supported assets are planned for the future. HyperCore is the native trading engine that handles on-chain order books and trading functions for Hyperliquid. With this listing, users can trade xStocks products linked to the prices of individual stocks and ETFs within the Hyperliquid ecosystem. Tokenized stocks are products that implement the economic exposure of stocks or ETFs as blockchain tokens, and the 1:1 collateral and separate custody do not imply shareholder status for token holders. It is important to distinguish the issuance and custody structure of each product, the sales regions, and the legal rights concerning the underlying assets. xStocks plans to gradually increase the types of tokenized assets supported on HyperCore.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.














Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.